344 related articles for article (PubMed ID: 19447208)
41. Tailoring nanocarriers for intracellular protein delivery.
Gu Z; Biswas A; Zhao M; Tang Y
Chem Soc Rev; 2011 Jul; 40(7):3638-55. PubMed ID: 21566806
[TBL] [Abstract][Full Text] [Related]
42. Nanocarriers in effective pulmonary delivery of siRNA: current approaches and challenges.
Bardoliwala D; Patel V; Javia A; Ghosh S; Patel A; Misra A
Ther Deliv; 2019 May; 10(5):311-332. PubMed ID: 31116099
[TBL] [Abstract][Full Text] [Related]
43. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
44. Patenting of nanopharmaceuticals in drug delivery: no small issue.
du Toit LC; Pillay V; Choonara YE; Pillay S; Harilall SL
Recent Pat Drug Deliv Formul; 2007; 1(2):131-42. PubMed ID: 19075880
[TBL] [Abstract][Full Text] [Related]
45. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.
Chen S; Hanning S; Falconer J; Locke M; Wen J
Eur J Pharm Biopharm; 2019 Nov; 144():18-39. PubMed ID: 31446046
[TBL] [Abstract][Full Text] [Related]
46. Targeted drug delivery to macrophages.
Jain NK; Mishra V; Mehra NK
Expert Opin Drug Deliv; 2013 Mar; 10(3):353-67. PubMed ID: 23289618
[TBL] [Abstract][Full Text] [Related]
47. Colloidal soft matter as drug delivery system.
Bonacucina G; Cespi M; Misici-Falzi M; Palmieri GF
J Pharm Sci; 2009 Jan; 98(1):1-42. PubMed ID: 18452176
[TBL] [Abstract][Full Text] [Related]
48. Recent progress in dendrimer-based nanocarriers.
Bai S; Thomas C; Rawat A; Ahsan F
Crit Rev Ther Drug Carrier Syst; 2006; 23(6):437-95. PubMed ID: 17425500
[TBL] [Abstract][Full Text] [Related]
49. Review of patents and application of spray drying in pharmaceutical, food and flavor industry.
Patel BB; Patel JK; Chakraborty S
Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):63-78. PubMed ID: 24720661
[TBL] [Abstract][Full Text] [Related]
50. Design of multifunctional nanocarriers for delivery of anti-cancer therapy.
Mehra NK; Jain K; Jain NK
Curr Pharm Des; 2015; 21(42):6157-64. PubMed ID: 26503145
[TBL] [Abstract][Full Text] [Related]
51. Enhanced skin penetration of lidocaine through encapsulation into nanoethosomes and nanostructured lipid carriers: a comparative study.
Babaei S; Ghanbarzadeh S; Adib ZM; Kouhsoltani M; Davaran S; Hamishehkar H
Pharmazie; 2016 May; 71(5):247-51. PubMed ID: 27348967
[TBL] [Abstract][Full Text] [Related]
52. Advances in Nanocarriers for Anticancer Drugs Delivery.
Ali I; Lone MN; Suhail M; Mukhtar SD; Asnin L
Curr Med Chem; 2016; 23(20):2159-87. PubMed ID: 27048343
[TBL] [Abstract][Full Text] [Related]
53. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.
Hua S; Marks E; Schneider JJ; Keely S
Nanomedicine; 2015 Jul; 11(5):1117-32. PubMed ID: 25784453
[TBL] [Abstract][Full Text] [Related]
54. Dendrimers and the development of new complex nanomaterials for biomedical applications.
Gardikis K; Micha-Screttas M; Demetzos C; Steele BR
Curr Med Chem; 2012; 19(29):4913-28. PubMed ID: 22963629
[TBL] [Abstract][Full Text] [Related]
55. Dermal Drug Delivery by Nanocarriers.
Wischke C; Rühl E; Lendlein A
J Control Release; 2016 Nov; 242():1-2. PubMed ID: 27863596
[No Abstract] [Full Text] [Related]
56. Microfluidics: a focus on improved cancer targeted drug delivery systems.
Khan IU; Serra CA; Anton N; Vandamme T
J Control Release; 2013 Dec; 172(3):1065-74. PubMed ID: 23933524
[TBL] [Abstract][Full Text] [Related]
57. Bioinspired Platform Conjugated Active Drug Delivery.
Shao J; Xuan M; He Q; Dai L
Curr Drug Targets; 2018 Feb; 19(4):328-338. PubMed ID: 27262485
[TBL] [Abstract][Full Text] [Related]
58. Albumin-based nanoparticles as potential controlled release drug delivery systems.
Elzoghby AO; Samy WM; Elgindy NA
J Control Release; 2012 Jan; 157(2):168-82. PubMed ID: 21839127
[TBL] [Abstract][Full Text] [Related]
59. Colloidal drug delivery system: amplify the ocular delivery.
Ali J; Fazil M; Qumbar M; Khan N; Ali A
Drug Deliv; 2016; 23(3):710-26. PubMed ID: 24892625
[TBL] [Abstract][Full Text] [Related]
60. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review.
Kanamala M; Wilson WR; Yang M; Palmer BD; Wu Z
Biomaterials; 2016 Apr; 85():152-67. PubMed ID: 26871891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
